191 related articles for article (PubMed ID: 23905893)
1. Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
Szczepanski MJ; Whiteside TL
Biomark Med; 2013 Aug; 7(4):575-8. PubMed ID: 23905893
[No Abstract] [Full Text] [Related]
2. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention in head and neck cancer.
Mellott A; Vokes E
Cancer Treat Res; 2001; 106():221-35. PubMed ID: 11225004
[No Abstract] [Full Text] [Related]
5. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.
Scully C; Field JK; Tanzawa H
Oral Oncol; 2000 Sep; 36(5):404-13. PubMed ID: 10964046
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
Le QT; Giaccia AJ
Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
[TBL] [Abstract][Full Text] [Related]
7. Squamous Cell Carcinoma Antigen-encoding Genes
Saidak Z; Morisse MC; Chatelain D; Sauzay C; Houessinon A; Guilain N; Soyez M; Chauffert B; Dakpé S; Galmiche A
Anticancer Res; 2018 Mar; 38(3):1343-1352. PubMed ID: 29491058
[TBL] [Abstract][Full Text] [Related]
8. Aurora sheds light on head and neck squamous cell carcinoma.
Han H; Von Hoff DD
Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
[No Abstract] [Full Text] [Related]
9. Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.
Theodoraki MN; Lorenz KJ; Schneider J; Thierauf JC; Spagnoli G; Schuler PJ; Hoffmann TK; Laban S
Anticancer Res; 2016 Aug; 36(8):3973-82. PubMed ID: 27466502
[TBL] [Abstract][Full Text] [Related]
10. [The amplification of 11q13 DNA markers in squamous-cell carcinomas in the head-neck area: a correlation with the clinical course].
Rödel C
Strahlenther Onkol; 1998 Dec; 174(12):642-3. PubMed ID: 9879354
[No Abstract] [Full Text] [Related]
11. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Yamashita Y; Matayoshi S; Kiyuna A; Agena S; Uehara T; Maeda H; Suzuki M
Cancer Sci; 2012 Dec; 103(12):2127-34. PubMed ID: 22937809
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of head and neck cancer.
Glover KY; Papadimitrakopoulou VA
Curr Oncol Rep; 2003 Mar; 5(2):152-7. PubMed ID: 12583833
[TBL] [Abstract][Full Text] [Related]
14. Genomic screening of head and neck cancer and its implications for therapy planning.
Szyfter K
Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):295-6. PubMed ID: 16575585
[No Abstract] [Full Text] [Related]
15. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.
Fan S; Zheng H; Zhan Y; Luo J; Zang H; Wang H; Wang W; Xu Y
Crit Rev Oncol Hematol; 2024 Jan; 193():104223. PubMed ID: 38036157
[TBL] [Abstract][Full Text] [Related]
17. Is gene expression profiling of head and neck cancers ready for the clinic?
Ziober AF; D'Alessandro L; Ziober BL
Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
[TBL] [Abstract][Full Text] [Related]
18. Advances in chemoprevention of head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Oncologist; 2004; 9(3):302-11. PubMed ID: 15169985
[TBL] [Abstract][Full Text] [Related]
19. Emerging Concepts in Head and Neck Squamous Cell Carcinoma.
Prystowsky MB
Arch Pathol Lab Med; 2015 Nov; 139(11):1332-3. PubMed ID: 26516936
[No Abstract] [Full Text] [Related]
20. Head and Neck Cancer in the New Era of Precision Medicine.
Nör JE; Gutkind JS
J Dent Res; 2018 Jun; 97(6):601-602. PubMed ID: 29771196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
